COVID-19 Vaccine Market is estimated to be US$ 25.85 billion by 2030 with a CAGR of 7.4% during the forecast period

Download Sample

Published Date: March 2024

The SARS-Cov2 virus causes COVID-19, which is a pneumonic disease. SARS-CoV and MERS Virus were COVID-19's forefathers. The mutation in the genetic material of SARS-CoV2 was caused by the loss of a few base pairs. A COVID-19 pandemic has erupted around the world. WHO and collaborators are racing to create and deploy safe and effective vaccines as they work together on the response to monitor the pandemic, advise on crucial measures, and distribute essential medical resources to those in need. Every year, millions of lives are saved thanks to vaccines. Vaccines function by instructing and preparing the body's natural defences – the immune system – to identify and combat the viruses and bacteria they are designed to combat. If the body is later exposed to disease-causing germs after vaccination, the body is able to kill them right away, avoiding illness. Vaccines are an important new weapon in the fight against COVID-19, and the fact that so many vaccines are proving to be effective and are being developed is extremely promising.

The report " COVID-19 Vaccine Market, By Product (Monovalent vaccine, and Multivalent vaccine), By Technology (Nucleic acid-based, Vector based, Protein based, and Whole virus), By Patients (Adult, Paediatric and Senior citizens), and By End-user (Vaccination centers, Clinics, Hospitals, Research institute, Academic and Others) - Market Trends, Analysis, and Forecast till 2030

Key Highlights:

In 2021, AstraZeneca-Oxford expects to produce 3 billion doses, Pfizer-BioNTech 1.3 billion doses, and Sputnik V, Sinopharm, Sinovac, and Johnson & Johnson each one billion doses.
More than 200 vaccine candidates are currently being developed, with more than 60 of them in clinical trials. COVAX is a component of the ACT Accelerator, which WHO and collaborators launched in 2020.

Analyst View:

Vaccines are a vital new weapon in the fight against COVID-19, and the fact that so many vaccines have proven to be effective and are being developed is extremely promising. Scientists from around the world are working and innovating as rapidly as they can to offer us experiments, medications, and vaccines that can save lives and put an end to the pandemic. Because the degree to which vaccinations can protect not only against disease but also against infection and transmission is still unknown, being vaccinated does not mean we can throw caution to the wind and put ourselves and others at risk. The global concerted effort to create vaccines to combat COVID-19 and deliver them to millions of people around the world in less than a year is an unprecedented achievement in the history of medicine and a victory for vaccine research and growth.

"Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “ COVID-19 Vaccine Market, By Product (Monovalent vaccine, and Multivalent vaccine), By Technology(Nucleic acid-based, Vector based, Protein based, and Whole virus), By Patients (Adult, Paediatric and Senior citizens), and By End-user(Vaccination centers, Clinics, Hospitals, Research institute, Academic and Others) - Market Trends, Analysis, and Forecast till 2030

Key Market Insights from the report:

COVID-19 Vaccine Market is estimated to be US$ 25.85 billion by 2030 with a CAGR of 7.4% during the forecast period. The Covid-19 Vaccine Market is segmented based on the product, technology, patients, & End-user.

By product, the Covid-19 Vaccine Market is segmented into monovalent vaccine and multivalent vaccine.
By Technology, the market is segmented into Nucleic acid-based, Vector based, Protein based, and whole virus.
By Patient, the Covid-19 Vaccine Market is segmented into Adult, Paediatric, and Senior citizens.
By End-user, the Covid-19 Vaccine Market is segmented into Vaccination centers, Clinics, Hospitals, Research Institute, Academic and Others.

Competitive Landscape:

The key players operating in the Covid-19 Vaccine Market include Astellas Pharma Inc., Daiichi Sankyo Company Ltd., Abbott Laboratories, CSL Ltd., GlaxoSmithKline plc, Moderna Inc., BioNTech SE, Novavax Inc., Johnson & Johnson, and AstraZeneca plc., Bharat Biotech, Pfizer, CureVac, SinoVac, Sinopharm. These industry behemoths are forming alliances and forming collaborations to increase their production capacity and profit margins in order to meet rising demand.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Some Important Points Answered in this Market Report Are Given Below:

Explains an overview of the product portfolio, including product development, planning, and positioning
Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.
Detailed analysis of the market revenue over the forecasted period.
Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis.
Study on the segments that are anticipated to dominate the market.
Study on the regional analysis that is expected to register the highest growth over the forecast period

Key Topics Covered